Death caused by orphenadine poisoning.
The number of deaths as a consequence of orphenadine poisoning seems to increase, mostly among severely psychotic males. The lethal dose corresponds to the weekly average dose used in the treatment of neuroleptic extrapyramidal side effects. Based on the literature, the serious, rapidly incipient, cardiac, and neurologic symptoms of poisoning are emphasized. The handing out of orphenadine to suicidal persons must be restricted, and even small overdoses (1-2 g) ought to result in the immediate initiation of observation at an intensive care unit.
D000293:Adolescent; D000328:Adult; D003430:Cross-Sectional Studies; D003718:Denmark; D005260:Female; D006778:Hospitals, Psychiatric; D006801:Humans; D008297:Male; D008875:Middle Aged; D009966:Orphenadrine / Q000506:poisoning*; D012565:Schizophrenic Psychology; D013405:Suicide / Q000453:epidemiology
D009966:Orphenadrine